Evidence map›Paper›PMID 41945214›Full record

ReviewNano-micro letters2026

Engineering of Asymmetric Dual-Atom Sites for Effective Oxygen Electrocatalysis.

Dongping Xue, Yu Zhao, Jianliang Cao, Yan Wang

Abstract readReview
In one paragraph

Review in Nano-micro letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dongping XueCollege of Chemistry and Chemical Engineering, Henan Polytechnic University, Jiaozuo, 454003, People's Republic of China.
Yu ZhaoCollege of Chemistry and Chemical Engineering, Henan Polytechnic University, Jiaozuo, 454003, People's Republic of China.
Jianliang CaoCollege of Chemistry and Chemical Engineering, Henan Polytechnic University, Jiaozuo, 454003, People's Republic of China.
Yan WangCollege of Safety Science and Engineering, Henan Polytechnic University, Jiaozuo, 454003, People's Republic of China. yanwang@hpu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asymmetric dual-atom site catalysts (ADASCs) inherit the high atomic utilization of single-atom site catalysts and synergistic effects of symmetric dual-atom site catalysts, while uniquely integrating the asymmetry of heteronuclear metal centers and asymmetric coordination environments. This structural merit endows them with tunable electronic configurations and optimized reaction kinetics, breaking conventional catalysts' inherent limitations to boost catalytic performance significantly. Despite existing reviews on dual-atom site catalysts for electrocatalysis, a comprehensive asymmetry-focused framework to elucidate ADASCs' catalytic behaviors remains elusive. This review summarizes the multi-dimensional regulation mechanisms of ADASCs. Structurally, heteronuclear metal synergy and bridging ligand co-anchoring suppress single-atom agglomeration. Electronically, d-band center modulation, spin coupling, and orbital hybridization optimize intermediate adsorption energies. Subsequently, the strategies for constructing asymmetric structures are elaborated, including the design of heteronuclear metal centers and the regulation of asymmetric coordination environments via nonmetallic atom engineering. Furthermore, the prominent advantages of ADASCs in oxygen electrocatalysis are highlighted as their asymmetric configurations can break the linear scaling relationship of intermediate adsorption, and optimize the reaction pathway as well as the adsorption behaviors of key intermediates. Finally, the current challenges and opportunities of ADASCs are discussed, providing valuable insights for the development of high-performance energy conversion devices.

Indexed as

Asymmetric dual-atom sitesOxygen electrocatalysisSpin configurationSynergetic effect

Identifiers

PMID41945214
PMCPMC13057091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.